Market revenue in 2023 | USD 106.2 million |
Market revenue in 2030 | USD 233.3 million |
Growth rate | 11.9% (CAGR from 2023 to 2030) |
Largest segment | Scaffold based |
Fastest growing segment | Scaffold Free |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Scaffold Based, Scaffold Free, Bioreactors, Microfluidics, Bioprinting |
Key market players worldwide | Thermo Fisher Scientific Inc, Merck KGaA, PROMOCELL, Lonza Group Ltd, Corning Inc, Avantor Inc, Tecan Group AG, ReproCELL, CN Bio |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to 3d cell culture market will help companies and investors design strategic landscapes.
Scaffold based was the largest segment with a revenue share of 48.78% in 2023. Horizon Databook has segmented the UK 3d cell culture market based on scaffold based, scaffold free, bioreactors, microfluidics, bioprinting covering the revenue growth of each sub-segment from 2018 to 2030.
For years, cell-based assays have been considered crucial for drug development in providing precise and cost-effective tools other than the conventional animal models. 3D cell culture has become a boon for cell-based assays as 3D cellular models mirror the in vivo environment of diseased tissues.
Market expansion coupled with a developed regulatory framework in this region is contributing to segment growth. Furthermore, international collaborations among research institutes have accelerated the growth of the healthcare system as 3D cell culture technology enables the assessment of potential efficacy of drugs with greater accuracy as compared to 2D, thus yielding effective drugs to combat diseases.
This has emphasized the need for further developments in this technology, consequently resulting in higher market growth in this country. High risk of failure in the translation of scientific discoveries into treatments leads to reluctance in investment by private organizations. However, simplification & elucidation of the regulatory system, support from innovative funding models, and growing number of clinical trials are anticipated to accelerate the market growth.
Horizon Databook provides a detailed overview of country-level data and insights on the UK 3d cell culture market , including forecasts for subscribers. This country databook contains high-level insights into UK 3d cell culture market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account